SPRYCEL: payments to doctors
Payments that named SPRYCEL as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $233K
- Providers
- 1,044
- Transactions
- 1,487
- Average per transaction
- $157
The per-transaction average — $157 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,044 providers the average total is $223, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | $227,918 | 97.9% |
| Bristol Myers Squibb | $3,454 | 1.5% |
| Otsuka America Pharmaceutical, Inc. | $1,494 | 0.6% |